Stifel Financial Corp Has $414,000 Stock Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Stifel Financial Corp lowered its position in Astrana Health, Inc. (NASDAQ:ASTH) by 4.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,142 shares of the company’s stock after selling 662 shares during the period. Stifel Financial Corp’s holdings in Astrana Health were worth $414,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Astrana Health in the 4th quarter worth about $40,000. KBC Group NV lifted its holdings in Astrana Health by 108.4% in the 4th quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after buying an additional 1,316 shares during the period. US Bancorp DE lifted its stake in shares of Astrana Health by 3,880.0% in the 4th quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after purchasing an additional 4,656 shares during the period. Pictet Asset Management Holding SA increased its position in Astrana Health by 21.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company’s stock valued at $223,000 after buying an additional 1,273 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its holdings in shares of Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company’s stock worth $225,000 after purchasing an additional 1,184 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Trading Down 6.4%

ASTH opened at $26.70 on Wednesday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $1.50 billion, a P/E ratio of 20.54, a PEG ratio of 1.37 and a beta of 1.00. The stock’s fifty day moving average is $30.92 and its two-hundred day moving average is $35.88. Astrana Health, Inc. has a 52 week low of $23.12 and a 52 week high of $63.20.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09). The company had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm’s revenue was up 53.4% compared to the same quarter last year. During the same period last year, the business posted $0.31 EPS. Analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on ASTH shares. Robert W. Baird cut their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Bank of America decreased their target price on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a research report on Tuesday, March 4th. Stifel Nicolaus decreased their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Truist Financial decreased their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research report on Tuesday, March 18th. Finally, Barclays assumed coverage on Astrana Health in a research report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price objective on the stock. Three research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $53.29.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.